Clinical Trials
4 trialsNCT06369480 2024-04-17
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Unknown
NCT05672537 2023-01-05
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT02103179 2014-04-03
VEGF ECC
First Affiliated Hospital, Sun Yat-Sen University
Unknown
NCT01917370 2013-08-06
icc
First Affiliated Hospital, Sun Yat-Sen University
Unknown